Inactive Instrument

Zenyatta Ventures Ltd Share Price Toronto S.E.

Equities

CA98943A1012

Biotechnology & Medical Research

Financials

Sales 2022 0.35 0.47 27.64 Sales 2023 0.07 0.1 5.8 Capitalization 206M 282M 16.4B
Net income 2022 -38M -51.93M -3.03B Net income 2023 -14M -19.13M -1.11B EV / Sales 2022 1,031,593,065 x
Net cash position 2022 24.44M 33.4M 1.95B Net cash position 2023 8.75M 11.95M 696M EV / Sales 2023 2,707,984,696 x
P/E ratio 2022
-9.19 x
P/E ratio 2023
-14.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 94.07%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 10/07/18
Director of Finance/CFO - 15/05/22
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 04/07/22
Director/Board Member 61 04/10/23
Chief Operating Officer - 10/05/18
More insiders
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
More about the company